-
1.
Ellison DH, Felker GM. Diuretic treatment in heart failure. N Engl J Med 2017; 377:1964–1975. doi: 10.1056/NEJMra1703100
-
2.
Mentz RJ, et al. Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: The TRANSFORM-HF randomized clinical trial. JAMA 2023; 329:214–223. doi: 10.1001/jama.2022.23924
-
3.
Lee M-C, et al. Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials. Medicine (Baltimore) 2022; 101:e32489. doi: 10.1097/MD.0000000000032489
-
4.
Duo Y, et al. Effect of sodium-glucose cotransporter 2 inhibitors on the rate of decline in kidney function: A systematic review and meta-analysis. J Diabetes 2023; 15:58–70. doi: 10.1111/1753-0407.13348
-
5.
Bart BA, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012; 367:2296–2304. doi: 10.1056/NEJMoa1210357
-
6.
Felker GM, et al. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med 2011; 364:797–805. doi: 10.1056/NEJMoa1005419
Torsemide versus Furosemide: No Difference after All?
Search for other papers by Klodia Hermez in
Current site
Google Scholar
PubMed
Search for other papers by James E. Novak in
Current site
Google Scholar
PubMed
© 2021 American Society of Nephrology | All Rights Reserved
Powered by: PubFactory